Bibliographic Details
| Title: |
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy. |
| Authors: |
Seung Tae Kim1, Jeeyun Lee1, Se Hoon Park1, Joon Oh Park1, Young Suk Park1, Won Ki Kang1, Ho Yeong Lim1 hoy.lim@samsung.com, Kim, Seung Tae2 (AUTHOR), Lee, Jeeyun2 (AUTHOR), Park, Se Hoon2 (AUTHOR), Park, Joon Oh2 (AUTHOR), Park, Young Suk2 (AUTHOR), Kang, Won Ki2 (AUTHOR), Lim, Ho Yeong2 (AUTHOR) |
| Source: |
BMC Cancer. 3/23/2017, Vol. 17, p1-6. 6p. 3 Charts, 1 Graph. |
| Database: |
Academic Search Ultimate |
